Pfizer's Chief Executive Albert Bourla plans to meet Starboard Value next week with at least one other director after the activist investor acquired a $1 billion stake in the healthcare company, the Financial Times reports, citing sources.
--The planned meeting shows Starboard's demands are getting a hearing at the highest levels of the company, the FT reports.
--Starboard's exact recommendations couldn't be ascertained and the firm declined to comment, the FT reports, adding that Pfizer didn't immediately respond to a request for comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.